A possible link between Celebrex and related drugs and the life-threatening skin reaction Stevens Johnson Syndrome was seen at least a decade ago.
In a 2005 study, published in the peer-reviewed journal Drug Safety, researchers used data collected by the FDA to spot the potential link to SJS.
The FDA helps perform what is called post-market surveillance, collecting information about drugs once they hit the market. The FDA’s post-market surveillance tools include a database called Adverse Event Reporting System (AERS). Here, researchers used data from AERS to estimate the rate of possible Celebrex side effects, including Stevens Johnson Syndrome.
Researchers found that in the first two years that Celebrex and related drugs had been on the market, there were 246 reports of Stevens Johnson Syndrome in patients taking drugs in the Celebrex family. Of these reports, 43 were reported by patients taking Celebrex (celecoxib). This was second only to one other drug in the class.
Researchers estimated that Stevens Johnson Syndrome was reported at a rate three times higher than normal among Celebrex patients. When looking at Valdecoxib, a drug related to Celebrex, researchers found an even higher rate, 25 times the background rate of Stevens Johnson Syndrome.
Researchers recommended that doctors prescribing Celebrex and related drugs be aware that Stevens Johnson Syndrome is a possible Celebrex side effect.
Stevens Johnson Syndrome is an autoimmune reaction. This means that in Stevens Johnson Syndrome, the body’s immune system goes haywire and attacks the body’s own tissue.
In the case of Stevens Johnson Syndrome, the body attacks the skin. SJS symptoms start with generalized, flu-like symptoms, including fever, muscle aches, and chills. But SJS symptoms escalate to a painful rash, then sores, blisters, and ulcers.
The study published in Drug Safety states that the researchers did not distinguish between Stevens Johnson Syndrome and an even more severe form of the disorder called Toxic Epidermal Necrolysis.
Toxic Epidermal Necrolysis (“TEN”) is considered a more severe part of the same spectrum that includes Stevens Johnson Syndrome. However, in Toxic Epidermal Necrolysis, the SJS rash progresses to the point that patches of skin die and slough off, leaving burn-like wounds all over the body. The mortality rate of Toxic Epidermal Necrolysis is a sliding scale based on the severity of the reaction, but as a whole, Toxic Epidermal Necrolysis has a higher mortality rate than some forms of the Ebola virus.
Many questions remain about Toxic Epidermal Necrolysis and Stevens Johnson Syndrome, but it appears that these reactions are nearly always caused by unusual reactions to drugs. The Drug Safety article suggests that Celebrex and related drugs may be among the drugs that can trigger Stevens Johnson Syndrome and Toxic Epidermal Necrolysis.
Often, cases of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis are not recognized right away, since the earliest SJS symptoms resemble many other diseases and reactions.
Additionally, there are few treatments available for Stevens Johnson Syndrome and Toxic Epidermal Necrolysis beyond supportive therapy, a term meaning “treating the symptoms and keeping the patient alive until the disease runs its course.”
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Stevens Johnson Syndrome attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. [In general, SJS lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2015 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Help for Victims of Stevens Johnson Syndrome
If you or a loved one were diagnosed with Stevens Johnson Syndrome (SJS) or toxic epidermal necrolysis (TEN) after taking a prescribed or over-the-counter medication, you may be eligible to take legal action against the drug’s manufacturer. Filing an SJS lawsuit or class action lawsuit may help you obtain compensation for medical bills, pain and suffering, and other damages. Obtain a free and confidential review of your case by filling out the form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Please list an emergency contact name and phone number:*
- What is the best time to call you?*
- Were you, or a loved one, medically diagnosed with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis?*
YesNo
- What year(s) were you or your loved one diagnosed with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis?*
- Please select which symptoms you or your loved one were medically diagnosed with:*
-
Stevens Johnson Syndrome.
-
Toxic Epidermal Necrolysis.
-
Not Listed (please detail the symptoms in the comments section if this is selected.)
-
No diagnosis/injury
-
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- Have you already retained an attorney to file a Stevens Johnson Syndrome lawsuit or a Toxic Epidermal Necrolysis lawsuit?
NoYes
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 27) {gformInitChosenFields(‘#input_27_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_27_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_27_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [27, 1]) } );
The post Celebrex Link to SJS Rash Discussed by Researchers appeared first on Top Class Actions.
No comments:
Post a Comment